Discontinued — last reported Q3 '23
Humana Equity Method Investments decreased by 0.8% to $633.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $659.00M to $633.00M. Over 4 years (FY 2021 to FY 2025), Equity Method Investments shows an upward trend with a 45.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $141.00M | $749.00M | $739.00M | $733.00M | $740.00M | $730.00M | $736.00M | $729.00M | $697.00M | $659.00M | $636.00M | $623.00M | $638.00M | $633.00M |
| QoQ Change | — | +431.2% | -1.3% | -0.8% | +1.0% | -1.4% | +0.8% | -1.0% | -4.4% | -5.5% | -3.5% | -2.0% | +2.4% | -0.8% |
| YoY Change | — | +431.2% | — | — | -1.2% | -1.2% | +0.4% | — | -5.8% | -9.7% | -13.6% | -14.5% | -8.5% | -3.9% |